Caricamento...
Trabectedin as a single agent and in combination with pegylated liposomal doxorubicin – activity against ovarian cancer cells
Over 225 000 new cases of ovarian cancer are diagnosed each year. Symptoms are often vague, so most cases are detected when the disease is at an advanced stage. There is a need to find new drugs which will be able to treat ovarian cancer effectively. One of the most promising antineoplastic agents i...
Salvato in:
| Pubblicato in: | Contemp Oncol (Pozn) |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Termedia Publishing House
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268992/ https://ncbi.nlm.nih.gov/pubmed/25520572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2014.43153 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|